Nua raises $50M to widen women’s wellness range and distribution

Mumbai-based Nua has raised a $50 million Series C led by Peak XV Partners and Filter Capital. The women’s wellness brand will deploy the capital into brand building, R&D, portfolio expansion and distribution across ecommerce, quick commerce and offline retail.

— Source publishedMon, 7 Sept, 2026, 10:25 IST·First seen Mon, 7 Sept, 2026, 10:29 IST·Source Inc42

What happened

Mumbai-based women’s wellness brand Nua raised $50 Mn in Series C funding led by Peak XV and Filter Capital. It will invest in brand building, distribution

Key facts

  • $50 Mn (₹472 Cr) Series C funding
  • Total funding exceeds $65 Mn
  • ₹35 Cr ($3.9 Mn) pre-Series C in February 2025
  • Founded in 2017
  • Serves over 3 Mn women and girls monthly
  • Annualised revenue run rate rose fivefold from ₹100 Cr to ₹500 Cr in 24 months
  • Pee Safe raised $32 Mn
  • Healthfab raised ₹20 Cr ($2.4 Mn)
  • India femtech market projected at $5.5 Bn by 2034; 15.7% CAGR from 2026-2034

Why this matters

Nua’s funding and platform ambition make it a stronger strategic partner or acquisition watchlist candidate for consumer-health players seeking women’s wellness exposure in India.

What to watch

  • Nua’s entry into new categories beyond menstrual care, especially higher-margin repeat-purchase products.
  • Availability and ranking across Blinkit, Zepto, Swiggy Instamart, Amazon, Flipkart and major pharmacy chains.
  • Evidence of modern-trade or general-trade distributor appointments and metro store-count expansion.
  • Changes in gross margin, customer acquisition cost, repeat rates and quick-commerce promotional intensity.
  • Competitive responses from established feminine-care, D2C wellness and pharmacy brands.
  • Follow-on hiring in retail sales, supply chain, R&D, regulatory affairs or category management.
  • Launch adjacent women’s wellness products that leverage the existing period-care customer base and first-party data.
  • Prioritize quick-commerce exclusives, emergency-use packs and subscription-to-instant-delivery conversion offers.
  • Build modern-trade and pharmacy distribution in top metros before broad general-trade rollout.
  • Increase brand investment around trust, efficacy and stigma reduction to defend against larger FMCG entrants.
  • Use the funding round to strengthen supply planning, regional fulfillment and channel-level profitability measurement.

Also reported by